+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

From
From
Cellular Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Cellular Immunotherapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
CAR T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Alpha Galactosidase A - Pipeline Review, H2 2019 - Product Thumbnail Image

Alpha Galactosidase A - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 84 Pages
  • Global
From
From
Kidney Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 191 Pages
  • Global
From
From
From
Targeted Immunotherapy in Oncology - Product Thumbnail Image

Targeted Immunotherapy in Oncology

  • Report
  • November 2021
  • 106 Pages
  • Global
From
Hemophilia B (Factor IX Deficiency) - Pipeline Review, H2 2020 - Product Thumbnail Image

Hemophilia B (Factor IX Deficiency) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 159 Pages
  • Global
From
Thalassemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Thalassemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 215 Pages
  • Global
From
From
Cholangiocarcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cholangiocarcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Loading Indicator